Finanzwire Finanzwire
Basculer en Français
9472 Companies
185369 Keywords
117719 Articles
99261 Press releases
Headlines Articles Press releases Endear Health Remove
  1. Home
  2. Companies
  3. Endear Health
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 11/04/2024 at 16:05, 1 year 1 month ago

    Endear Health Collaborates with Doctors HealthCare Plans on New Member Portal

    Healthcare Technology Digital Healthcare Medicare Advantage Member Portal Florida Health Plans
  • PRESS RELEASE

    published on 11/04/2024 at 16:00, 1 year 1 month ago

    Endear Health Partners With Doctors HealthCare Plans, Launches New Medicare Advantage Member Portal

    Endear Health and Doctors HealthCare Plans partner to launch a digital member portal for Medicare Advantage members in Miami. Portal offers easy access to health information and benefits
    Healthcare Technology Medicare Advantage Endear Health Doctors HealthCare Plans Digital Member Portal
    Logo of Endear Health
  • PRESS RELEASE

    published on 08/09/2023 at 16:20, 2 years 3 months ago

    Endear Health Announces $8M in New Funding From Optum Ventures, Blue Cross of Idaho, 8VC and Additional Strategic Partners

    Logo of Endear Health
Accesswire
  • Published on 12/05/2025 at 02:35, 3 hours 39 minutes ago

    Future Fuels Initates Drill Permitting at Hornby; Marketing Update

  • Published on 12/05/2025 at 02:30, 3 hours 44 minutes ago

    Klondike Gold Announces AGM Results

  • Published on 12/05/2025 at 01:00, 5 hours 14 minutes ago

    BEACN Closes First Tranche of Non-Brokered Private Placement

  • Published on 12/04/2025 at 23:05, 7 hours 9 minutes ago

    BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025

  • Published on 12/04/2025 at 23:00, 7 hours 14 minutes ago

    NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE
EQS Group
  • Published on 12/05/2025 at 03:30, 2 hours 43 minutes ago

    CGTN: What makes cooperation between China and France a two-way success

  • Published on 12/04/2025 at 23:50, 6 hours 23 minutes ago

    EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes

  • Published on 12/04/2025 at 20:25, 9 hours 48 minutes ago

    Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions

  • Published on 12/04/2025 at 20:15, 9 hours 59 minutes ago

    Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025

  • Published on 12/04/2025 at 19:10, 11 hours 3 minutes ago

    SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

View all EQS
Les Echos
  • Published on 12/04/2025 at 18:00, 12 hours 14 minutes ago

    Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025

  • Published on 12/04/2025 at 17:45, 12 hours 29 minutes ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

  • Published on 12/04/2025 at 17:44, 12 hours 30 minutes ago

    Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution

  • Published on 12/04/2025 at 07:01, 23 hours 13 minutes ago

    bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

  • Published on 12/03/2025 at 18:00, 1 day 12 hours ago

    Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2025 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy